Table of Contents
International Journal of Molecular Imaging
Volume 2015 (2015), Article ID 391625, 9 pages
http://dx.doi.org/10.1155/2015/391625
Research Article

99mTechnetium Sestamibi-123Iodine Scintigraphy Is More Accurate Than 99mTechnetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism

1Division of Endocrinology, Department of Medicine, Helsinki University Central Hospital, University of Helsinki, 00029 Helsinki, Finland
2HUS Medical Imaging Center, Department of Clinical Physiology and Nuclear Medicine, Helsinki University Central Hospital, 00029 Helsinki, Finland
3Department of Surgery, Helsinki University Central Hospital, 00029 Helsinki, Finland
4Department of Biostatistics, University of Turku, 20520 Turku, Finland

Received 28 September 2014; Revised 14 December 2014; Accepted 19 December 2014

Academic Editor: Irene J. Virgolini

Copyright © 2015 Eeva M. Ryhänen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Sosa, N. R. Powe, M. A. Levine, R. Udelsman, and M. A. Zeiger, “Profile of a clinical practice: thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons,” The Journal of Clinical Endocrinology and Metabolism, vol. 83, no. 8, pp. 2658–2665, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Hindié, Ö. Ugur, D. Fuster et al., “2009 EANM parathyroid guidelines,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 36, no. 7, pp. 1201–1216, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. A. J. Coakley, A. G. Kettle, C. P. Wells, M. J. O'Doherty, and R. E. C. Collins, “99Tcm sestamibi—a new agent for parathyroid imaging,” Nuclear Medicine Communications, vol. 10, no. 11, pp. 791–794, 1989. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Crane, R. Laliberté, S. Heminway, M. Thoolen, and C. Orlandi, “Effect of mitochondrial viability and metabolism on technetium99m-sestamibi myocardial retention,” European Journal of Nuclear Medicine, vol. 20, no. 1, pp. 20–25, 1993. View at Publisher · View at Google Scholar
  5. B. K. Mitchell, E. A. Cornelius, S. Zoghbi et al., “Mechanism of technetium 99m sestamibi parathyroid imaging and the possible role of p-glycoprotein,” Surgery, vol. 120, no. 6, pp. 1039–1045, 1996. View at Publisher · View at Google Scholar · View at Scopus
  6. D. R. Neumann, C. B. Esselstyn Jr., R. T. Go, C. O. Wong, T. W. Rice, and N. A. Obuchowski, “Comparison of double-phase 99mtechnetium-sestamibi with 123iodine-99mtechnetium-sestamibi subtraction SPECT in hyperparathyroidism,” The American Journal of Roentgenology, vol. 169, no. 6, pp. 1671–1674, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. N. A. Johnson, M. E. Tublin, and J. B. Ogilvie, “Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism,” American Journal of Roentgenology, vol. 188, no. 6, pp. 1706–1715, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Caveny, W. C. Klingensmith III, W. E. Martin et al., “Parathyroid imaging: the importance of dual-radiopharmaceutical simultaneous acquisition with Tc99m-sestamibi and 123I,” Journal of Nuclear Medicine Technology, vol. 40, no. 2, pp. 104–110, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. P. Bilezikian, J. T. Potts Jr., G. El-Hajj Fuleihan et al., “Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century,” The Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 12, pp. 5353–5361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. C. C. Chen, L. E. Holder, W. A. Scovill, A. M. Tehan, and D. S. Gann, “Comparison of parathyroid imaging with technetium-99mpertechnetate/sestamibisubstraction, double-phase Tc99m-sestamibi and Tc99m-sestamibi SPECT,” Journal of Nuclear Medicine, vol. 38, no. 6, pp. 834–839, 1997. View at Google Scholar
  11. E. Hindié, D. Mellière, C. Jeanguillaume, L. Perlemuter, F. Chéhadé, and P. Galle, “Parathyroid imaging using simultaneous double-window recording of technetium-99m-sestamibi and iodine-123,” Journal of Nuclear Medicine, vol. 39, no. 6, pp. 1100–1105, 1998. View at Google Scholar · View at Scopus
  12. W. D. Leslie, J. O. Dupont, B. Bybel, and K. T. Riese, “Parathyroid Tc99m-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout,” European Journal of Nuclear Medicine, vol. 29, no. 12, pp. 1566–1570, 2002. View at Publisher · View at Google Scholar · View at Scopus
  13. V. Tunninen, P. Varjo, J. Schildt et al., “Comparison of five parathyroid scintigraphic protocols,” International Journal of Molecular Imaging, vol. 2013, Article ID 921260, 12 pages, 2013. View at Publisher · View at Google Scholar
  14. M. Philippon, C. Guerin, D. Taieb et al., “Bilateral neck exploration in patients with primary hyperparathyroidism and discordant imaging results: a single-centre study,” European Journal of Endocrinology, vol. 170, no. 5, pp. 719–725, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Wakamatsu, S. Noguchi, H. Yamashita et al., “Parathyroid scintigraphy with Tc99m-MIBI and 123I subtraction: a comparison with magnetic resonance imaging and ultrasonography,” Nuclear Medicine Communications, vol. 24, no. 7, pp. 755–762, 2003. View at Google Scholar · View at Scopus
  16. C. Schalin-Jäntti, E. Ryhänen, I. Heiskanen et al., “Planar scintigraphy with 123I/Tc99m-sestamibi, Tc99m-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?” Journal of Nuclear Medicine, vol. 54, no. 5, pp. 739–747, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Hassler, D. Ben-Sellem, F. Hubele, A. Constantinesco, and C. Goetz, “Dual-isotope Tc99m-MIBI/123I parathyroid scintigraphy in primary hyperparathyroidism: comparison of subtraction SPECT/CT and pinhole planar scan,” Clinical Nuclear Medicine, vol. 39, no. 1, pp. 32–36, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. F. H. Jorna, P. L. Jager, T. H. Que, C. Lemstra, and J. T. M. Plukker, “Value of 123I-subtraction and single-photon emission computed tomography in addition to planar Tc99m-MIBI scintigraphy before parathyroid surgery,” Surgery Today, vol. 37, no. 12, pp. 1033–1041, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. J. M. Jones, C. F. J. Russell, W. R. Ferguson, and J. D. Laird, “Pre-operative sestamibi-technetium subtraction scintigraphy in primary hyperparathyroidism: experience with 156 consecutive patients,” Clinical Radiology, vol. 56, no. 7, pp. 556–559, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Civelek, E. Ozalp, P. Donovan, and R. Udelsman, “Prospective evaluation of delayed technetium-99m sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism,” Surgery, vol. 131, no. 2, pp. 149–157, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. E. Berber, R. T. Parikh, N. Ballem, C. N. Garner, M. Milas, and A. E. Siperstein, “Factorscontributing to negativeparathyroidlocalization: an analysis of 1000 patients,” Surgery, vol. 144, no. 1, pp. 74–79, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. E. Hindié, D. Mellière, C. Jeanguillaume, P. Ureña, C. DeLabriolle-Vaylet, and L. Perlemuter, “Unilateral surgery for primary hyperparathyroidism on the basis of Tc99m-sestamibi/123I substraction scanning,” Archives of Surgery, vol. 135, no. 12, pp. 1461–1468, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Siperstein, E. Berber, G. F. Barbosa et al., “Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases,” Annals of Surgery, vol. 248, no. 3, pp. 420–426, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. W. Shen, U. Sabanci, E. T. Morita, A. E. Siperstein, Q.-Y. Duh, and O. H. Clark, “Sestamibi scanning is inadequate for directing unilateral neck exploration for first-time parathyroidectomy,” Archives of Surgery, vol. 132, no. 9, pp. 969–976, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Norman, J. Lopez, and D. Politz, “Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations,” Journal of the American College of Surgeons, vol. 214, no. 3, pp. 260–269, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Allendorf, L. Kim, J. Chabot, M. DiGiorgi, K. Spanknebel, and P. Logerfo, “The impact of sestamibi scanning on the outcome of parathyroid surgery,” The Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 7, pp. 3015–3018, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. E. Hindié, D. Mellière, L. Perlemuter, C. Jeanguillaume, and P. Galle, “Primary hyperparathyroidism: higher success rate of first surgery after preoperative Tc99m-sestamibi-123I-subtraction scanning,” Radiology, vol. 204, no. 1, pp. 221–228, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. J. P. Wei and G. J. Burke, “Analysis of savings in operative time for primary hyperparathyroidism using localization with Tc99m-sestamibi scan,” American Journal of Surgery, vol. 170, no. 5, pp. 488–491, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Udelsman, J. L. Pasieka, C. Sturgeon, J. E. M. Young, and O. H. Clark, “Surgery for asymptomatic primary hyperparathyroidism: proceedings of the third International Workshop,” The Journal of Clinical Endocrinology and Metabolism, vol. 94, no. 2, pp. 366–372, 2009. View at Publisher · View at Google Scholar · View at Scopus